Axonics Modulation Technologies
Irvine
About Axonics Modulation Technologies
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $735.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (Aug 2022)
- Ticker: nasdaq:AXNX
- Website: axonics.com
- Phone: (949) 396-6322
Industries & Categories
Health Diagnostics, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/axonics-modulation-technologies-28563 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.